Deteriorating results
The other half of “breakout results”: companies whose filings inside the window went the other way. Same rules, opposite direction.
Viewing the mirror. ← Back to breakout results (526 companies)
| Company | Why it’s here — the filing | Reaction 1d / 1w / 1m | Price | Mcap |
|---|---|---|---|---|
| Q1 FY27 results: PAT falls 34% YoY, dividend record date Aug 5 | +9.4% +11.6% — | ₹2,219 | 1.80 L Cr | |
| Board approves Q1 FY27 results with mixed performance | -3.2% -5.2% — | ₹860 | 21,311 Cr | |
| The Board of Directors of Glenmark Pharmaceuticals Limited considered and approved audited financial results and recommended dividend. | -5.0% -6.4% -6.0% | ₹2,318 | 65,411 Cr | |
| Oil & Natural Gas Corporation Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | -7.5% -7.9% -18.6% | ₹236 | 2.97 L Cr |
How this list is built
A company appears when an NSE/BSE filing inside the last 90 days carries one of these classifier signals (minimum importance: Medium): Revenue Decline, Pat Negative, Ebitda Margin Compression. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.
MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.